Moneycontrol Be a Pro
Get App
Last Updated : Dec 08, 2011 11:15 PM IST | Source: CNBC-TV18

Lupin hopeful of getting Fortamet case through

Lupin had launched Fortamet, a diabetic drug, at risk in the US, causing an injunction against the drug. Chief Financial Officer S Ramesh clarified that Fortamet generic was launched only for few days.


Lupin had launched Fortamet, a diabetic drug, at risk in the US, causing an injunction against the drug. The company had not checked with the company which holds the patent or the regulators.


Chief Financial Officer S Ramesh clarified that Fortamet generic was launched only for few days. "There is no timeline for resolution of legislation on Fortamet generic," he added.


Here is the edited transcript of his interview to CNBC-TV18. Also watch the accompanying video.


Q: What would you lose by way of sales? If the case is lost, what's the potential loss?

A: We would lose an opportunity. We expected to get about USD 50-60 million in terms of sales on the particular product. This has caused an injunction, which doesn

Are you happy with your current monthly income? Do you know you can double it without working extra hours or asking for a raise? Rahul Shah, one of the India's leading expert on wealth building, has created a strategy which makes it possible... in just a short few years. You can know his secrets in his FREE video series airing between 12th to 17th December. You can reserve your free seat here.

First Published on Dec 8, 2011 05:31 pm
Loading...
Follow us on
Available On